Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06090071 · ClinicalTrials.gov registry record · Phase 4
Trial Evaluating Both Tolerability and Improvement for Signs of Facial Photoaging, Discoloration, and Texture in Adult Females of All Skin Types by Combining a Placebo Moisturizer and Non-ablative Laser.
A Phase 4 study, sponsored by Austin Institute for Clinical Research.
- Completed
- Registry status
- Phase 4
- Development phase
- 38
- Enrollment target
NCT06090071 is a Phase 4 study that has completed, run by Austin Institute for Clinical Research. The registered enrollment target is 38 participants.
The verdict
NCT06090071, a Phase 4 study, has completed, sponsored by Austin Institute for Clinical Research.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 38 participants
- Enrollment target
Study Summary
This is a phase 4 trial evaluating the clinical effect of combining a placebo moisturizer and non-ablative laser to improve procedural outcomes in patients with facial dyschromia. This study's objective is to evaluate both the tolerability and improvement in signs of photoaging for a placebo moisturizer used in combination with a non-ablative laser. Physician assessments, patient reported outcomes, and digital photos will be captured.
Interventions
- DEVICE LaseMD Laser
- DEVICE Sciton Laser
- DRUG Phyto A+ Brightening Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2023-11-14 |
| Est. Completion | 2024-09-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06090071
The ClinicalTrials.gov registry entry for NCT06090071 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Austin Institute for Clinical Research, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which LaseMD Laser is the first listed.
NCT06090071 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06090071 about?
NCT06090071 is a clinical study titled "Trial Evaluating Both Tolerability and Improvement for Signs of Facial Photoaging, Discoloration, and Texture in Adult Females of All Skin Types by Combining a Placebo Moisturizer and Non-ablative Laser.". This is a phase 4 trial evaluating the clinical effect of combining a placebo moisturizer and non-ablative laser to improve procedural outcomes in patients with facial dyschromia. This study's objective is to evaluate both the tolerability and improvement in signs of photoaging for a placebo moistur...
What is the current status of trial NCT06090071?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 38 participants. The study started on 2023-11-14. Estimated completion is 2024-09-05.
What interventions are being tested in trial NCT06090071?
The interventions under investigation include: LaseMD Laser (DEVICE), Sciton Laser (DEVICE), Phyto A+ Brightening Treatment (DRUG).
Who is sponsoring clinical trial NCT06090071?
This trial is sponsored by Austin Institute for Clinical Research, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.